Kohjin Bio Co., Ltd. (TYO:177A)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Cell Processing Business	974.78M	1.16B	1.21B	-	-
Microbial Business	1.42B	1.78B	1.66B	-	-
Tissue Culture Business	2.54B	2.27B	1.90B	-	-
Biotechnology	-	-	-	4.74B	-
Total	4.94B	5.21B	4.77B	4.74B	-

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Japan	3.96B	4.31B	4.13B	4.36B	-
Asia (Excluding China)	109.95M	129.73M	-	-	-
Europe	450.00K	373.00K	184.00K	50.00K	-
China	865.09M	766.79M	-	-	-
Asia	-	-	637.60M	385.34M	-
Total	4.94B	5.21B	4.77B	4.74B	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error